We are delighted to announce that the results of the clinical phase I study on quantitative fluorescence endoscopy using bevacizumab-800CW in patients with locally advanced rectal cancer is published in the journal Gut (2019 impact factor: 17.943) The full citation is: Tjalma JJJ, Koller M, Linssen MD, et al. Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment
The article “Roadmap for the development and clinical translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW” has been published in the Journal of Nuclear Medicine. The full citation is: Linssen, M. D., ter Weele, E. J., Allersma, D. P., Lub-de Hooge, M. N., van Dam, G. M., Jorritsma-Smit, A., & Nagengast, W. B. (2019). Roadmap for
We are delighted to announce that the results of the clinical phase II study on image-guided surgery using bevacizumab-IRDye800CW in patients with primary breast cancer is published in the journal Nature Communications (2017 impact factor: 12.353) We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes. The full citation is: Koller M, Qiu
Young Investigator Award Last Friday Marjory Koller was one of the three finalist competing for the young investigator award at the European Molecular Imaging Meeting 2018 in San Sebastian, Spain. During a plenary session she presented our work entitled: ”Quantitative Fluorescence Endoscopy: a new and promising tool to Predict and Evaluate Response to neoadjuvant chemoradiotherapy